Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chen YM et al. – The use of interferon beta–1a 44 micro g via subcutaneous injection three times weekly did not increase the ON attacks in MS patients receiving this treatment. In addition, beneficial effects were found with the use of interferon beta–1a on these patients.

Related Articles

Optic neuritis - More than a loss of vision
Australian Family Physician, 10/05/09    Relevance Score: 67%

Multiple sclerosis. Part I: Neuro-ophthalmic manifestations
Current Opinion in Ophthalmology, 10/29/09    Relevance Score: 65%

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
The Lancet - Early Online Publication, 11/02/09    Relevance Score: 64%

Magnetic Resonance Imaging in Acute Optic Neuritis in Singapore
Annals, Academy of Medicine, Singapore, 10/13/09    Relevance Score: 64%

Optical diagnosis of small colorectal polyps at routine colonoscopy (Detect InSpect ChAracterise Resect and Discard; DISCARD trial): A prospective cohort study
The Lancet Oncology - Online First, 11/12/09    Relevance Score: 46%

Today in Neuro-Ophthalmology...keeping you current

Bilateral Ocular Hypertension with Rapidly Progressive Optic Neuropathy in a Teen
Optometry and Vision Science, 12/08/09

Management of Symptomatic Meesmann Dystrophy
Optometry and Vision Science, 12/04/09

Thyroid Eye Disease: Pathogenesis and Treatment
Ophthalmologica, 12/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address